The authors evaluated the activity of trospectomycin, a new aminocycli
tol which is characterized by good antibacterial and broad spectrum ac
tivity, in comparison with clindamycin and ampicillin on a sample of r
ecent isolates: Bacteroides fragilis (15 strains), Bacteroides urealyt
icus (5 strains), Bacteroides vulgatus (5 strains), Bacteroides spp. (
15 strains), Prevotella melaninogenica (6 strains), Porphyromonas asac
charolytica (7 strains), Mobiluncus spp. (3 strains), Peptococcus nige
r (3 strains), Peptococcus variabilis (3 strains), Peptococcus spp (30
strains), Peptostreptococcus anaerobius (5 strains), Peptostreptococc
us asaccharolyticus (3 strains), Peptostreptococcus spp. (25 strains)
and Propionibacterium spp. (7 strains). The minimum inhibitory concent
ration (MIC) and minimum bactericidal concentration (MBC) were determi
ned for all strains by microtiter serial dilutions in Wilkins-Chalgren
broth in an anaerobic chamber in an atmosphere of 10% H-2, 10% CO2, 8
0% N-2. All the drugs tested exert their activity against Gram-positiv
e and Gram-negative anaerobic isolates. In particular, trospectomycin
is quite active against Grampositive cocci (MIC 90 = 4 - 8 mg/l), Gram
-negative rods (MIC 90 = 8 - 16 mg/l), Gram-positive rods (MIC 90 = 4
mg/l) and Mobiluncus spp. (MIC 30 = 0.5 mg/l).